| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |